CARLSBAD, Calif. — After Arash Moradzadeh, MD, treated the first 100 consecutive patients in his practice with a 1726-nm laser (AviClear) following its Food and Drug Administration (FDA) clearance for ...
“The topline results from Ascletis’ Phase 3 open-label acne trial in China build additional confidence in the clinical potential of FASN inhibition in acne,” said David Happel, Chief Executive Officer ...
After struggling with his <a href="https://www.menshealth.com/grooming/g26074982/best-face-wash-for-acne-men/" id="d8f0756f-824b-39fe-a941-4e56109b92f9"> acne </a ...
Clinical Trials Arena on MSN
Ascletis reports positive results in Phase III denifanstat trial for acne
Denifanstat showed tolerability and a favourable safety profile and most TEAEs were mild or moderate.
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Picture this: You just got out of bed after a long night’s rest and you’re feeling super refreshed and ...
Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...
Acne is the most common skin condition in the United States and its effects can be devastating. However, successful treatment can be hard to come by. "I have had problems with my skin for as long as I ...
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Acne is nobody’s BFF. In fact, it’s the enemy we ...
Please provide your email address to receive an email when new articles are posted on . Topical triple-agent fixed-dose combination had the best log-ratio for treatment success. It also proved to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results